Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 1, 2010, Pages 54-63

  Heike, Carrie L ^a   Starr, Jacqueline R ^a   Rieder, Mark J ^a   Cunningham, Michael L ^a   Edwards, Karen L ^a   Stanaway, Ian B ^a   Crawford, Dana C ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

22q11.2 deletion syndrome; Single nucleotide polymorphism discovery; TBX1

Indexed keywords

T BOX TRANSCRIPTION FACTOR;

ARTICLE; ASIAN; BINDING SITE; CHILD; CHROMOSOME 22Q; CHROMOSOME 22Q DELETION SYNDROME; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC MARKER; HAPLOTYPE; HISPANIC; HUMAN; INDEL MUTATION; MALE; NEGRO; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ABNORMALITIES, MULTIPLE; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNDROME; T-BOX DOMAIN PROTEINS; WASHINGTON;

EID: 75749107536     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20604     Document Type: Article

References (49)

1. Aggarwal VS, Morrow BE. 2008. Genetic modifiers of the physical malformations in velo-cardio-facial syndrome/DiGeorge syndrome. Dev Disabil Res Rev 14(1):19-25.
2. Arnold JS, Braunstein EM, Ohyama T, et al. 2006a. Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Hum Mol Genet 15(10):1629-1639.
3. Arnold JS, Werling U, Braunstein EM, et al. 2006b. Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations. Development 133(5):977-987.
4. Bhangale TR, Rieder MJ, Livingston RJ, Nickerson DA. 2005. Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes. Hum Mol Genet 14(1):59-69.
5. Bhangale TR, Rieder MJ, et al. 2008. Estimating coverage and power for genetic association studies using near-complete variation data. Nat Genet 40:841-843.
6. Botto LD, May K, Fernhoff PM, et al. 2003. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112(1 Pt 1):101-107.
7. Cabuk F, Karabulut HG, Tuncali T, et al. 2007. TBX1 gene mutation screening in patients with non-syndromic Fallot tetralogy. Turk J Pediatr 49(1):61-68.
8. Carlson CS, Eberle MA, Rieder MJ, et al. 2004. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74(1):106-120.
9. Chieffo C, Garvey N, Gong W, et al. 1997. Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene. Genomics 43(3):267-277.
10. Conti E, Grifone N, Sarkozy A, et al. 2003. DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 gene. Eur J Hum Genet 11(4):349-351.
11. Crawford DC, Akey DT, Nickerson DA. 2005. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 6:287-312.
12. Devriendt K, Fryns J, Mortier G, et al. 1998. The annual incidence of DiGeorge/velocardiofacial syndrome. Am J Med Genet 35:789-790.
13. Fagman H, Liao J, Westerlund J, et al. 2007. The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning. Hum Mol Genet 16(3):276-285.
14. Gong W, Gottlieb S, Collins J, et al. 2001. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 38(12):E45.
15. Han XM, Lou Y, Zhu XY, et al. 2006. Single nucleotide polymorphism and haplotype in TBX1 gene of patients with conotruncal defects: analysis of 130 cases. Zhonghua Yi Xue Za Zhi 86(22):1553-1557 (in Chinese).
16. Hoogendoorn B, Coleman SL, Guy CA, et al. 2004. Functional analysis of polymorphisms in the promoter regions of genes on 22q11. Hum Mutat 24(1):35-42.
17. Howie BN, Carlson CS, Rieder MJ, Nickerson DA. 2006. Efficient selection of tagging single-nucleotide polymorphisms in multiple populations. Hum Genet 120(1):58-68.
18. International HapMap Consortium. 2003. The International HapMap Project. Nature 426(6968):789-796.
19. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27(3):286-291.
20. Kruglyak L. 2008. The road to genome-wide association studies. Nat Rev 9(4):314-318.
21. Kruglyak L, Nickerson DA. 2001. Variation is the spice of life. Nat Genet 27(3):234-236.
22. Lindsay EA, Vitelli F, Su H, et al. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410(6824):97-101.
23. Livingston RJ, von Niederhausern A, Jegga AG, et al. 2004. Pattern of sequence variation across 213 environmental response genes. Genome Res 14(10A):1821-1831.
24. Ma G, Shi Y, Tang W, et al. 2007. An association study between the genetic polymorphisms within TBX1 and schizophrenia in the Chinese population. Neurosci Lett 425(3):146-150.
25. McDonald-McGinn DM, Kirschner R, Goldmuntz E, et al. 1999. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10(1):11-24.
26. Merscher S, Funke B, Epstein JA, et al. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104(4):619-629.
27. Ng PC, Henikoff S. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812-3814.
28. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. 2004. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32(Web Server issue):W280-W286.
29. Pritchard JK, Przeworski M. 2001. Linkage disequilibrium in humans: models and data. Am J Hum Genet 69(1):1-14.
30. Pritchard JK, Rosenberg NA. 1999. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65(1):220-228.
31. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30(17):3894-3900.
32. Rauch A, Devriendt K, Koch A, et al. 2004. Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients. J Med Genet 41(4):e40.
33. Robin NH, Shprintzen RJ. 2005. Defining the clinical spectrum of deletion 22q11.2. J Pediatr 147(1):90-96.
34. Ryan AK, Goodship JA, Wilson DI, et al. 1997. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34(10):798-804.
35. Shprintzen RJ. 2005. Velo-cardio-facial syndrome. In: Cassidy SB, Allanson JE, editors. Management of genetic syndromes. 2nd ed. New York: Wiley-Liss. pp. 615-631.
36. Stephens M, Donnelly P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73(5):1162-1169.
37. Stephens M, Sloan JS, Robertson PD, et al. 2006. Automating sequencebased detection and genotyping of SNPs from diploid samples. Nat Genet 38(3):375-381.
38. Tajima F. 1989. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123(3):585-595.
39. Theveniau-Ruissy M, Dandonneau M, Mesbah K, et al. 2008. The del22q11.2 candidate gene Tbx1 controls regional outflow tract identity and coronary artery patterning. Circ Res 103(2):142-148.
40. Vitelli F, Morishima M, Taddei I, et al. 2002. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet 11(8):915-922.
41. Vitelli F, Viola A, Morishima M, et al. 2003. TBX1 is required for inner ear morphogenesis. Hum Mol Genet 12(16):2041-2048.
42. Vittorini S, Sacchelli M, Iascone MR, et al. 2001. Molecular characterization of chromosome 22 deletions by short tandem repeat polymorphism (STRP) in patients with conotruncal heart defects. Clin Chem Lab Med 39(12):1249-1258.
43. Voelckel MA, Girardot L, Giusiano B, et al. 2004. Allelic variations at the haploid TBX1 locus do not influence the cardiac phenotype in cases of 22q11 microdeletion. Ann Genet 47(3):235-240.
44. Wilson D, Cross I, Wren C, et al. 1994. Minimum prevalence of chromosome 22q11 deletions. Am J Med Genet 55:A169.
45. Wiltshire S, de Bakker PI, Daly MJ. 2006. The value of gene-based selection of tag SNPs in genome-wide association studies. Eur J Hum Genet 14(11):1209-1214.
46. Yagi H, Furutani Y, Hamada H, et al. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362(9393):1366-1373.
47. Yamagishi H, Maeda J, Hu T, et al. 2003. Tbx1 is regulated by tissue-specific forkhead proteins through a common sonic hedgehog-responsive enhancer. Genes Dev 17(2):269-281.
48. Yamagishi H, Srivastava D. 2003. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol Med 9(9):383-389.
49. Zweier C, Sticht H, Aydin-Yaylagul I, et al. 2007. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 80(3):510-517.